Troy Wichterman (Chief Financial Officer) sold ~$25K of BioLife Solutions, Inc.
Scheduled in advanceLoading…
Traded Dec 9, 2025 · Filed Dec 17, 2025
BioLife Solutions's Chief Marketing Officer sold $9K of BioLife Solutions shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$8,997
Shares × reported transaction price
33 days after results of Nov 6, 2025, 34 days before results of Jan 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.7% | +2.0% | −3.8% |
| 30 days | −2.3% | +0.2% | −2.5% |
| 90 days | −24.6% | −2.2% | −22.3% |
| 180 days | +4.0% | +10.9% | −6.9% |
Past results only. Not a forecast.
Troy Wichterman (Chief Financial Officer) sold ~$25K of BioLife Solutions, Inc.
Scheduled in advanceKaren A. Foster (Chief Quality and Operations) sold ~$8.6K of BioLife Solutions, Inc.
Scheduled in advanceSarah Aebersold (Chief Human Resources Officer) sold ~$6.2K of BioLife Solutions, Inc.
Scheduled in advance